However, there is only one approved drug, setmelanotide for POMC-LEPR deficiency [10], and there is no treatment for other POMC-MC4R pathway-deficient diseases, such as POMC-null, MSH-deficiency, and patients with PWS with obesity
The 1990s saw continued research into GHRPs as potential clinical solutions for a variety of diseases and disorders, with the first studies to investigate GHRPs in growth hormone deficiencies
The 25.4-fold increase in collagen IV when combined with hyaluronic acid indicates significant structural improvement potential
Knapen LM, de Jong RG, Driessen JH, Keulemans YC, van Erp NP, De Bruin ML, Leufkens HG, Croes S, de Vries F
"Seems paradoxical to think that GLPs can both improve and dampen erections, but it's true," Turek lamented